Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill T Walker

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|March 24, 2020
GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype CoverageWieslaw M Kazmierski, Sam Baskaran, Jill T Walker, et al.
Drugs in R&D|November 24, 2025
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, et al.
Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|March 24, 2020
GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype CoverageWieslaw M Kazmierski, Sam Baskaran, Jill T Walker, et al.
Drugs in R&D|November 24, 2025
Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical TrialAnil Gupta, Maria Teresa Perez-Rodríguez, Yaneicy Gonzalez-Rojas, et al.
Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.
Pageof 1